Juan R. Kojima, PA

Juan Kojima practices at Umansky Medical Management, Inc. in La Jolla, California.

Juan Kojima's NPI, 1033301528, was assigned on August 17, 2007. Juan Kojima holds California license PA19349.

Juan Kojima's primary practice is Umansky Medical Management, Inc., at 4150 Regents Park Row, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 550-9697.

Juan Kojima's primary practice is Umansky Medical Management, Inc. in La Jolla, California. Juan Kojima is also affiliated with Sharp Memorial Hospital. The medical group on file is Dr. Mona Mofid. Dmand AI also links Juan Kojima to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Juan Kojima practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Juan Kojima's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Juan Kojima is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Juan Kojima is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, chronic kidney disease, contact dermatitis, itchy rashes, joint cyst and psoriasis among the conditions Juan Kojima treats.

CMS data shows 3,603 Medicare services from Juan Kojima across 14 procedure codes in 2024, for 361 Medicare patients. Medicare paid $117,503 for them. Every service was in an office.

CMS counts 361 Medicare patients who saw Juan Kojima in 2024. The largest group is 65 to 74, with 203 patients. 69% of them have high cholesterol, and 61% have high blood pressure. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Juan Kojima's median patient age at 64, with 52% women.

In 2024, Juan Kojima wrote 502 Medicare Part D claims for 274 patients. 96% of them were for generic drugs. CMS names the drug for 370 of them, across 12 drugs with 11 or more claims each, at $28,021 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Juan Kojima for performance year 2024, reported individually. Juan Kojima accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 204 general payments to Juan Kojima from 15 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 95% of the total. Amgen Inc. paid the most, $918.